Ocular surface lipid layer and epithelial cell membrane (OSLL/ECM)

The ocular surface lipid layer and epithelial cell membranes constitute the primary physical and biological barrier of the eye, essential for maintaining optical clarity and comfort. The lipid layer, primarily secreted by meibomian glands, forms the outermost surface of the tear film to prevent excessive aqueous evaporation and provide a smooth optical interface (Willcox et al., 2017 [1]). Beneath this, the corneal and conjunctival epithelial cell membranes, stabilized by membrane-associated mucins, provide a hydrophobic barrier against pathogens and environmental insults (Gipson, 2007 [2]). Dysfunction in these components, such as in Meibomian Gland Dysfunction (MGD) or Dry Eye Disease (DED), leads to tear film instability, hyperosmolarity, and subsequent epithelial damage (Craig et al., 2017 [3]). Therapeutic interventions often target these structures directly; for instance, perfluorohexyloctane acts as a surfactant to stabilize the lipid layer and reduce evaporation (FDA, 2023 [4]). Other treatments, such as lipid-based lubricants and secretagogues, aim to restore the integrity of these layers to alleviate inflammation and promote surface healing (Jones et al., 2017 [5]). The health of the epithelial cell membranes is also supported by anti-inflammatory agents like cyclosporine, which indirectly improve barrier function by reducing T-cell mediated damage. Overall, these structures are critical targets for managing ocular surface diseases and ensuring the long-term health of the visual system.

Other names

Tear film lipid layerCorneal epitheliumConjunctival epitheliumOcular surface barrierTFLL

Reduction of tear evaporation, stabilization of the tear film, restoration of the lipid layer, and protection/lubrication of the corneal epithelium.